相关实验视频

Updated: Jul 24, 2025

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

基于tau的被动免疫治疗药物的临床开发,用于治疗初级和二级tau病变

Francesco Panza^1,2, Vittorio Dibello^2,3, Rodolfo Sardone^2,4

¹Dipartimento Interdisciplinare di Medicina, Clinica Medica E Geriatria "Cesare Frugoni", University of Bari Aldo Moro, Bari, Italy.

Expert opinion on investigational drugs

|July 5, 2023

概括

被动免疫疗法对包括阿尔茨海默氏症 (AD) 在内的多变性病具有前景. 虽然有几种抗tau抗体正在临床试验中,但没有一个达到III期,这凸显了进一步研究的必要性.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

陶病症涉及神经元和神经细胞中异常的陶蛋白聚合.
像阿尔茨海默病 (AD) 一样,初级和二级病症缺乏有效的疾病修饰治疗方法.
现有的治疗病症的症状药物具有有限的疗效.

研究的目的:

审查近期治疗初级和二级病的进展.
专注于基于tau的被动免疫疗法的发展和挑战.
评估临床试验中抗tau抗体的当前状态.

主要方法:

关于病治疗的当前文献的综述.
对基于tau的被动免疫疗法临床试验数据的分析.
专注于正在发展中的抗tau单克隆抗体.

主要成果:

14种抗抗体已经进入针对病的临床试验.
9种抗体正在临床测试中,用于进展性超核性麻和AD.
迄今为止,还没有任何抗tau抗体达到III期试验.
塞莫里内马布是最先进的阿尔茨海默病;贝普拉尼马布是渐进的超核性麻.

结论:

基于的被动免疫疗法是对病的发展战略.
目前正在进行的I/II期试验将为免疫治疗疗效提供进一步的见解.
在开发有效的疾病修饰治疗病症方面,仍然存在重大挑战.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.超级顶级域名 - 塔乌这是PSPSPSPSPSPS 痴呆症痴呆症是一种痴呆症.轻度的认知障碍轻度的认知障碍一个单克隆抗体.知道的知道的知道的陶氏病变是一种病变.

更多相关视频

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on ¹⁸F-AV-1451

Published on: April 18, 2025

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...